Clinical Trial Update: Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults [Phase 1]

View source ↗

Summary

This is a Phase 1 study of an investigational pneumococcal vaccine tested at three dose levels in healthy adults; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections
• Pneumococcal Pneumonia

Drugs mentioned

• Investigational pneumococcal vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Pneumococcal Infections, Streptococcus Pneumoniae Infections | Phase 1 | Status: COMPLETED